October 21, 2010 article Open access Lipoprotein(a) as a cardiovascular risk factor: current status European Heart Journal DOI: 10.1093/eurheartj/ehq386 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 11 stored of 1,828 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins 2026 Cardiovascular Diabetology article Medicine Lipoproteins and Cardiovascular Health Open access 3 citations The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK Biobank 2025 American Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access 6 citations Monocyte heterogeneity in cardiovascular disease 2023 Cardiovascular Research article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access 77 citations Developing an SI-traceable Lp(a) reference measurement system: a pilgrimage to selective and accurate apo(a) quantification 2023 Critical Reviews in Clinical Laboratory Sciences review Medicine Lipoproteins and Cardiovascular Health Open access 44 citations Novel and future lipid-modulating therapies for the prevention of cardiovascular disease 2023 Nature Reviews Cardiology review Medicine Lipoproteins and Cardiovascular Health 105 citations Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab 2022 Circulation article Medicine Lipoproteins and Cardiovascular Health Open access 117 citations Lipids and lipoproteins in cardiovascular diseases: a classification 2022 Trends in Endocrinology and Metabolism review Medicine Lipoproteins and Cardiovascular Health Open access 113 citations Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells 2021 European Journal of Immunology article Nursing Fatty Acid Research and Health Open access 21 citations Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM 2021 Laboratory Service article Medicine Lipoproteins and Cardiovascular Health 13 citations Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM 2020 Atherosclerosis article Medicine Lipoproteins and Cardiovascular Health Open access 240 citations Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 Journal of the American College of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access cited by 1 patent 604 citations 11 results References 0